247 related articles for article (PubMed ID: 35884812)
1. Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot Ulcer.
El Hage R; Knippschild U; Arnold T; Hinterseher I
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884812
[TBL] [Abstract][Full Text] [Related]
2. Stem Cell-Based Tissue Engineering Approaches for Diabetic Foot Ulcer: a Review from Mechanism to Clinical Trial.
Panda D; Nayak S
Stem Cell Rev Rep; 2024 Jan; 20(1):88-123. PubMed ID: 37867186
[TBL] [Abstract][Full Text] [Related]
3. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
Ejiugwo M; Rochev Y; Gethin G; O'Connor G
Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight.
Mahmoudvand G; Karimi Rouzbahani A; Razavi ZS; Mahjoor M; Afkhami H
Front Bioeng Biotechnol; 2023; 11():1158484. PubMed ID: 37122856
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.
Hetta HF; Elsaghir A; Sijercic VC; Akhtar MS; Gad SA; Moses A; Zeleke MS; Alanazi FE; Ahmed AK; Ramadan YN
Health Sci Rep; 2024 Apr; 7(4):e2036. PubMed ID: 38650719
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer.
Cao Y; Gang X; Sun C; Wang G
J Diabetes Res; 2017; 2017():9328347. PubMed ID: 28386568
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review.
Zhang HM; Yang ML; Xi JZ; Yang GY; Wu QN
World J Diabetes; 2023 Nov; 14(11):1585-1602. PubMed ID: 38077806
[TBL] [Abstract][Full Text] [Related]
8. Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats.
Shi R; Lian W; Jin Y; Cao C; Han S; Yang X; Zhao S; Li M; Zhao H
Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):620-630. PubMed ID: 32484226
[TBL] [Abstract][Full Text] [Related]
9. Novel biological therapies for the treatment of diabetic foot ulcers.
Adeghate J; Nurulain S; Tekes K; Fehér E; Kalász H; Adeghate E
Expert Opin Biol Ther; 2017 Aug; 17(8):979-987. PubMed ID: 28532226
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Diabetic Foot Ulcers in a Tertiary Referral Interdisciplinary Clinic: A Retrospective Canadian Study.
Fournier C; Singbo N; Morissette N; Thibeault MM
Can J Diabetes; 2021 Apr; 45(3):255-260. PubMed ID: 33160884
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Burden of Diabetic Foot Ulcer and Peripheral Arterial Disease in Korea.
Chun DI; Kim S; Kim J; Yang HJ; Kim JH; Cho JH; Yi Y; Kim WJ; Won SH
J Clin Med; 2019 May; 8(5):. PubMed ID: 31130633
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
Lin CJ; Lan YM; Ou MQ; Ji LQ; Lin SD
J Endocrinol Invest; 2019 Nov; 42(11):1307-1317. PubMed ID: 31079353
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of cilostazol and aspirin on wound healing in patients with diabetic foot ulcer and peripheral artery disease.
Colak B; Orhan A; Ece I; Yormaz S; Yilmaz H; Sahin M
Ann Ital Chir; 2020; 91():225-232. PubMed ID: 32719187
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of maggot debridement therapy in promoting wound angiogenesis in patients with diabetic foot ulcer].
Wang TY; Chen YC; Wang W; Jiang D; Liu L; Yang H; Wang AP
Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1040-1049. PubMed ID: 33238687
[No Abstract] [Full Text] [Related]
15. An assessment of peripheral vascular disease in patients with diabetic foot ulcer.
Ikem R; Ikem I; Adebayo O; Soyoye D
Foot (Edinb); 2010 Dec; 20(4):114-7. PubMed ID: 20951569
[TBL] [Abstract][Full Text] [Related]
16. Autologous platelet-rich gel combined with
Wu Q; Lei X; Chen L; Zheng Y; Huang H; Qian C; Liang Z
Ann Transl Med; 2018 Aug; 6(15):307. PubMed ID: 30211195
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1 may play pivotal role in distraction-stimulated neovascularization of diabetic foot ulcer.
Fang J; Xu J; Zhang Y; Chen H; Ma Z; Huang Z; Hu J
Med Hypotheses; 2021 Apr; 149():110548. PubMed ID: 33690002
[TBL] [Abstract][Full Text] [Related]
18. Burden of diabetic foot ulcer in Nigeria: Current evidence from the multicenter evaluation of diabetic foot ulcer in Nigeria.
Ugwu E; Adeleye O; Gezawa I; Okpe I; Enamino M; Ezeani I
World J Diabetes; 2019 Mar; 10(3):200-211. PubMed ID: 30891155
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with diabetic foot ulcer-free survival in patients with diabetes.
Yazdanpanah L; Shahbazian H; Nazari I; Hesam S; Ahmadi F; Cheraghian B; Arti HR; Mohammadianinejad SE
Diabetes Metab Syndr; 2018 Nov; 12(6):1039-1043. PubMed ID: 30168426
[TBL] [Abstract][Full Text] [Related]
20. Malnutrition and its relation with diabetic foot ulcer severity and outcome: a review.
Lauwers P; Dirinck E; Van Bouwel S; Verrijken A; Van Dessel K; Van Gils C; Sels M; Peiffer F; Van Schil P; De Block C; Hendriks J
Acta Clin Belg; 2022 Feb; 77(1):79-85. PubMed ID: 32727304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
